Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Lovestone

Showing results (291-300 of 333) with videos related to

Pageof 34
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 4, 2019
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R Morgan, Samuel Touchard, Claire Leckey, et al.
Neuromolecular Medicine|April 13, 2004
Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's diseaseVictoria Busby, Steven Goossens, Petra Nowotny, et al.
Annals of Neurology|January 7, 2015
Protective variant for hippocampal atrophy identified by whole exome sequencingKwangsik Nho, Sungeun Kim, Shannon L Risacher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohortsVeerle van Gils, Willemijn J Jansen, Wiesje M van der Flier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD studyRebecca G Smith, Ehsan Pishva, Morteza Kouhsar, et al.
Journal of Alzheimer'S Disease : JAD|February 4, 2017
A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's DiseaseWasim Khan, Vincent Giampietro, Tobias Banaschewski, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Pageof 34

Showing results (291-300 of 333) with videos related to

Sort By:
Pageof 34
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 4, 2019
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R Morgan, Samuel Touchard, Claire Leckey, et al.
Neuromolecular Medicine|April 13, 2004
Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's diseaseVictoria Busby, Steven Goossens, Petra Nowotny, et al.
Annals of Neurology|January 7, 2015
Protective variant for hippocampal atrophy identified by whole exome sequencingKwangsik Nho, Sungeun Kim, Shannon L Risacher, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohortsVeerle van Gils, Willemijn J Jansen, Wiesje M van der Flier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD studyRebecca G Smith, Ehsan Pishva, Morteza Kouhsar, et al.
Journal of Alzheimer'S Disease : JAD|February 4, 2017
A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's DiseaseWasim Khan, Vincent Giampietro, Tobias Banaschewski, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Pageof 34